Location History:
- Giessen, DE (2012)
- Polheim Watzenborn-Steinberg, DE (2019)
Company Filing History:
2 out of 13 
1 out of 1,289 
Years Active: 2012-2019
Title: Andreas Günther: Innovator in Cancer Research
Introduction
Andreas Günther is a notable inventor based in Munich, Germany. He has made significant contributions to the field of cancer research, particularly in the development of diagnostic and therapeutic methods. His work has led to the filing of multiple patents that aim to improve cancer diagnosis and treatment.
Latest Patents
Andreas Günther holds 2 patents. His latest patents include "Isoforms of GATA6 and NKX2-1 as markers for diagnosis and therapy of cancer and as targets for anti-cancer therapy." This invention relates to a method for assessing whether a subject suffers from cancer, specifically lung cancer, by measuring specific isoforms of GATA6 and/or NKX2-1 in a sample. Additionally, it includes a composition for medical use that comprises inhibitors of these isoforms and a kit for assessing cancer susceptibility.
Another significant patent is "Chimeric plasminogen activators and their pharmaceutical use." This invention involves recombinant chimeric proteins that fuse surfactant protein precursors to plasminogen activators. It also covers the nucleic acid molecules encoding these fusion proteins and their production methods. Furthermore, it refers to a pharmaceutical composition containing such fusion proteins for the prevention and treatment of inflammatory and interstitial lung diseases.
Career Highlights
Throughout his career, Andreas Günther has worked with esteemed institutions such as Justus Liebig University Giessen and the Max Planck Society for the Advancement of Science. His research has focused on innovative solutions in the medical field, particularly concerning lung diseases and cancer.
Collaborations
Andreas has collaborated with notable professionals in his field, including Werner Seeger and Clemens Ruppert. These collaborations have further enhanced his research and contributions to cancer therapy.
Conclusion
Andreas Günther is a prominent figure in cancer research, with a focus on innovative diagnostic and therapeutic methods. His patents reflect his commitment to advancing medical science and improving patient outcomes.